Moderna and Merck's Phase 2b study results for mRNA-4157 combined with Keytruda, showing improvements in recurrence-free and distant metastasis-free survival for high-risk melanoma patients. Phase 3 trials are now underway for melanoma and non-small cell lung cancer.
Apple (NASDAQ:AAPL) to showcase AI strategy at WWDC 2024, Goldman Sachs sets bullish price target of $226.00, partnership with OpenAI and ramping up production of M2 Ultra processors.
GSK shares fell as the Delaware State Court allowed over 70,000 lawsuits regarding the discontinued heartburn drug Zantac (ranitidine) to proceed. This ruling contradicts a Federal Court's 2022 decision dismissing similar cases, potentially increasing GSK's liability.
Ford plans to offer driverless technology in the next two years, aiming to attract customers with lucrative subscriptions, amid US safety regulator scrutiny.
Super Micro Computer, Inc. collaborates with Foxconn, KDDI, Sharp, and Datasection to build a large-scale AI data center in Japan powered by Nvidia's chips.